Mosaic ImmunoEngineering Inc. (CPMV)
About Mosaic ImmunoEngineering Inc.
MOSAIC IMMUNOENGINEERING
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$687.8K
- Total assets
- $19.9K
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Dividend yield
- 5.97%
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Mosaic ImmunoEngineering Inc. (CPMV) Stock Price
- Reported a net loss of $687.8K.
- Trading 36% below its 52-week high.
- Pays a dividend yielding about 5.97% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Mosaic ImmunoEngineering Inc..
Write a review
Mosaic ImmunoEngineering Inc.: frequently asked questions
Is Mosaic ImmunoEngineering Inc. an American company?
Mosaic ImmunoEngineering Inc. is a US-based company headquartered in Huntington Beach, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Mosaic ImmunoEngineering Inc. headquartered?
Mosaic ImmunoEngineering Inc. is headquartered in Huntington Beach, California, United States.
Is Mosaic ImmunoEngineering Inc. publicly traded?
Yes — Mosaic ImmunoEngineering Inc. is a publicly traded company. Its stock trades under the ticker symbol CPMV on the OTC.
What does Mosaic ImmunoEngineering Inc. do?
Mosaic ImmunoEngineering Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
